의료용 로봇 시장 - 세계 예측(2026-2032년)

The Medical Robots Market is projected to grow by USD 32.11 billion at a CAGR of 7.92% by 2032.

Medical robots are becoming a core enabler of precision medicine, digitally assisted care delivery, and operational resilience across hospitals, ambulatory surgical centers, rehabilitation facilities, pharmacies, and long-term care settings. The medical robotics landscape spans surgical robots, rehabilitation robots, hospital logistics robots, telepresence systems, pharmacy automation, radiation therapy support, and assistive devices used in patient mobility and nursing workflows. Adoption is being shaped by verified clinical and operational drivers, including demand for minimally invasive procedures, workforce shortages, aging populations, infection prevention requirements, and the need for more consistent clinical outcomes. Regulatory agencies in major healthcare markets continue to emphasize safety, cybersecurity, software validation, human factors engineering, usability, and post-market surveillance for robotic medical technologies. As healthcare providers shift from device-centric purchasing to outcome-based technology strategies, medical robots are increasingly evaluated on interoperability, training burden, procedural efficiency, total lifecycle support, service reliability, and measurable impact on patient care pathways.

Transformative Shifts in the Medical Robots Landscape

The medical robots industry is undergoing transformative shifts as robotics moves from specialized operating rooms into broader clinical ecosystems. Surgical robotics is expanding beyond traditional high-complexity procedures into orthopedics, neurosurgery, urology, gynecology, thoracic surgery, and image-guided interventions, supported by improved navigation, haptics, visualization, and instrument miniaturization. Rehabilitation robotics is gaining relevance as health systems address stroke recovery, spinal cord injury rehabilitation, geriatric mobility, and long-term functional improvement. Hospital automation is also advancing through autonomous mobile robots for medication delivery, specimen transport, linen movement, and disinfection workflows, helping care teams redirect time toward patient-facing activities. A major shift is the integration of robotics with connected hospital infrastructure, electronic health records, advanced imaging, remote monitoring platforms, and digital command centers. This is changing procurement priorities: decision-makers now look for open architecture, cybersecurity readiness, clinical workflow compatibility, staff training programs, uptime assurance, and evidence of reduced variability in care delivery. The landscape is also being shaped by value-based care, where robotic systems must demonstrate not only technical sophistication but also reliability, patient safety, and operational contribution across the full care continuum.

Cumulative Impact of Artificial Intelligence on Medical Robots

Artificial intelligence is having a cumulative impact on medical robots by enhancing perception, planning, decision support, workflow automation, and adaptive control. AI-enabled image analysis supports surgical navigation, anatomical segmentation, procedure planning, and intraoperative guidance, while machine learning models can help detect patterns in robotic performance, instrument use, and procedural workflow. In rehabilitation robotics, AI supports personalized therapy intensity, movement assessment, and adaptive assistance based on patient progress. In hospital logistics, AI improves route optimization, obstacle avoidance, task allocation, and integration with scheduling systems. However, the growing use of AI in medical robots also increases the importance of explainability, clinical validation, bias assessment, data governance, cybersecurity, and regulatory compliance. Authorities in advanced healthcare markets are strengthening expectations around software as a medical device, AI lifecycle management, real-world performance monitoring, human oversight, and change control for adaptive algorithms. The most durable opportunities are emerging where AI augments clinicians rather than replaces judgment, improves consistency without reducing accountability, and provides measurable benefits in safety, efficiency, documentation, and patient outcomes.

Key Regional Insights for Medical Robots

Europe demonstrates broad uptake of medical robots driven by universal healthcare systems, aging demographics, clinical quality initiatives, and regulatory emphasis on device safety, data protection, and evidence generation. Germany, France, Italy, Spain, and the United Kingdom are key contributors to surgical and rehabilitation robotics adoption, with strong attention to health technology assessment, procurement value, cybersecurity, and compliance with evolving medical device requirements. Asia-Pacific is a major growth environment for medical robots due to rising surgical volumes, aging populations in countries such as Japan, South Korea, China, and Australia, and expanding investments in digital hospitals and advanced medical infrastructure. The region shows strong demand for surgical robotics, rehabilitation robotics, and hospital automation, although adoption varies by reimbursement systems, hospital capital budgets, domestic manufacturing capacity, and surgeon training availability. North America remains one of the most mature regions for medical robots, supported by advanced hospital networks, high procedure volumes, established regulatory pathways, clinical research infrastructure, and strong adoption of minimally invasive and image-guided procedures. The United States and Canada are also prioritizing robotics in pharmacy automation, telehealth-enabled care, sterile processing support, and labor-saving hospital workflows. Latin America is developing steadily as private hospital networks and tertiary care centers invest in robotic surgery and digital care modernization, with Brazil and Mexico serving as important anchors; however, affordability, reimbursement, service infrastructure, and specialist training remain critical factors. The Middle East is increasingly investing in high-acuity hospitals, medical tourism, and advanced surgical platforms, particularly in GCC countries where healthcare transformation programs support digital and robotic infrastructure. Africa remains at an earlier stage of adoption, with opportunities centered on telepresence, training support, logistics automation, rehabilitation access, and targeted robotic surgery programs in leading urban hospitals, while infrastructure, affordability, maintenance, and skilled workforce availability continue to influence deployment.

Key Group Insights for Medical Robots

NATO countries, while not a healthcare market category by themselves, include many advanced medical technology adopters with interest in surgical preparedness, rehabilitation for trauma and mobility impairment, telemedicine, and resilient medical logistics, creating overlap between civilian healthcare modernization and defense medical readiness. G7 countries remain influential in medical robot innovation, clinical validation, regulatory standards, and adoption of high-acuity robotic platforms, with strong focus on patient safety, procedural outcomes, workforce productivity, cybersecurity, and evidence-based procurement. The European Union provides a highly structured environment for medical robots, shaped by medical device regulation, health data protection, clinical evidence expectations, post-market surveillance, and cross-border research collaboration; this creates strong demand for compliant, interoperable, and validated robotic solutions. BRICS economies represent a diverse opportunity base, combining large patient populations, expanding hospital infrastructure, and increasing interest in locally produced or cost-optimized robotic systems; China and India are especially relevant due to scale, engineering capacity, and public-private healthcare expansion, while Brazil, Russia, and South Africa show opportunities in specialized care centers and training-led deployment. ASEAN is becoming an important demand cluster for medical robots as countries invest in tertiary hospitals, medical tourism, digital health systems, and specialist surgical capabilities, with adoption concentrated in advanced urban facilities and private healthcare networks. The GCC is advancing rapidly through healthcare modernization strategies, high investment in specialty hospitals, and demand for robotic surgery, rehabilitation technologies, and automated hospital logistics that support premium care delivery and operational efficiency.

Key Country Insights for Medical Robots

The United States is a leading country for medical robots adoption due to advanced surgical infrastructure, high specialist availability, hospital technology investment, and strong clinical research activity across robotic surgery, rehabilitation, pharmacy automation, and hospital logistics. China is rapidly advancing through hospital modernization, domestic robotics development, large surgical demand, and policy support for high-end medical equipment. Germany benefits from strong engineering capabilities, hospital specialization, and a robust clinical technology ecosystem, making it a key European adopter of surgical and rehabilitation robots. Japan is a key robotics market due to demographic aging, engineering expertise, and demand for surgical assistance, rehabilitation, and eldercare robotics. India is expanding adoption across leading private hospitals and major urban centers, with strong potential tied to affordability, surgeon training, and high patient volumes. The United Kingdom is focused on surgical modernization, digital health integration, and evidence-based procurement, with increasing attention to robotics for productivity and patient outcomes. Brazil is the most prominent Latin American country for robotic surgery adoption, supported by large urban hospital networks and specialist centers, while reimbursement and training remain important adoption determinants. France emphasizes regulated, evidence-driven adoption across public and private hospitals, with growing interest in minimally invasive surgery and rehabilitation support. Mexico is emerging through private hospital investment, cross-border care dynamics, and demand for advanced surgical capabilities in major cities. Canada shows steady adoption supported by public healthcare modernization, academic medical centers, and demand for technologies that improve access and efficiency across geographically dispersed care systems. Australia demonstrates adoption across advanced hospitals and research institutions, supported by digital health maturity and demand for remote care capabilities. South Korea combines strong medtech innovation, advanced hospital infrastructure, and high technology acceptance, supporting robotic surgery, rehabilitation robotics, and healthcare automation. Italy and Spain show adoption in high-volume surgical centers, particularly where robotic systems support minimally invasive procedures and specialist care pathways. Russia has invested in selected advanced hospital programs and domestic technology capability, although access, procurement, and geopolitical constraints can affect deployment.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated robotics solutions that address clear pain points such as surgical precision, staff shortages, patient throughput, rehabilitation intensity, medication safety, and hospital logistics. Product strategies should emphasize interoperability with imaging systems, electronic health records, hospital command centers, cybersecurity frameworks, and remote service infrastructure. Vendors and healthcare providers should invest in structured training, simulation-based credentialing, and multidisciplinary adoption programs to reduce learning curves and improve safe utilization. Evidence generation should move beyond technical performance to include procedure time, complication reduction, length of stay, staff workload, patient-reported outcomes, uptime, maintenance requirements, and lifecycle cost transparency. Regional strategies should be tailored to reimbursement maturity, infrastructure readiness, regulatory requirements, and workforce availability rather than relying on one-size-fits-all commercialization. AI-enabled medical robots should be developed with explainable design, robust validation, data privacy protections, bias monitoring, and continuous performance monitoring protocols. Partnerships with hospitals, academic centers, rehabilitation networks, standards bodies, and public health agencies can accelerate adoption when they are tied to measurable clinical and operational outcomes.

Research Methodology

This executive summary is developed through a structured secondary research approach using publicly available and verifiable sources such as regulatory agency guidance, peer-reviewed clinical literature, hospital technology adoption reports, medical robotics standards, healthcare policy publications, demographic data, and industry-recognized clinical practice information. The analysis focuses on qualitative market intelligence, technology adoption patterns, regulatory developments, regional healthcare infrastructure, clinical use-case evolution, and AI-enabled workflow transformation. No market sizing, market share, or forecasting assumptions are included. Insights are synthesized by comparing evidence across regions, country-level healthcare systems, robotics application areas, AI integration trends, reimbursement conditions, and procurement drivers. The methodology emphasizes data reliability, source triangulation, relevance to medical robot deployment, and consistency with current regulatory, cybersecurity, and clinical evidence standards.

Conclusion

Medical robots are reshaping healthcare by enabling more precise procedures, supporting rehabilitation, automating repetitive hospital tasks, and strengthening remote and technology-enabled care delivery. The sector is being propelled by aging populations, surgical innovation, workforce constraints, digital hospital transformation, and the growing role of AI in clinical and operational workflows. Regional adoption is uneven, with advanced healthcare systems leading high-complexity deployment while emerging markets focus on targeted use cases, affordability, training, and infrastructure readiness. The most successful stakeholders will be those that align robotic technologies with validated clinical outcomes, regulatory compliance, human-centered workflows, cybersecurity, and scalable service models. As medical robots become more integrated into care pathways, their value will depend on how effectively they improve safety, efficiency, accessibility, and patient-centered outcomes across the global healthcare system.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Medical Robots Market, by Type Of Robot

• 7.1. Introduction
• 7.2. Disinfection Robots
• 7.3. Pharmacy Automation Robots
  • 7.3.1. Medication Delivery Robots
  • 7.3.2. Supply & Logistics Robots
• 7.4. Rehabilitation Robots
• 7.5. Surgical Robots
• 7.6. Radiosurgery Robots
  • 7.6.1. Stereotactic Radiosurgery Robots
  • 7.6.2. Radiotherapy Positioning Robots

8. Medical Robots Market, by Component

• 8.1. Introduction
• 8.2. Robotic Systems
  • 8.2.1. Drives
  • 8.2.2. Motion Controllers
  • 8.2.3. Sensors
• 8.3. Surgical Instruments & Accessories
  • 8.3.1. Arms & Articulators
  • 8.3.2. Disposable/Single-Use Instruments

9. Medical Robots Market, by Mobility

• 9.1. Introduction
• 9.2. Fixed
• 9.3. Portable

10. Medical Robots Market, by Mode of Operation

• 10.1. Introduction
• 10.2. Autonomous
• 10.3. Semi-Autonomous
  • 10.3.1. Task-Level Autonomy
  • 10.3.2. Procedure-Level Autonomy

11. Medical Robots Market, by Indication

• 11.1. Introduction
• 11.2. Cardiology
• 11.3. Gynecology
• 11.4. Neurosurgery
• 11.5. Oncology
• 11.6. Ophthalmology
• 11.7. Orthopedic
• 11.8. Urology

12. Medical Robots Market, by Application Area

• 12.1. Introduction
• 12.2. Diagnostics
• 12.3. Treatment

13. Medical Robots Market, by End User

• 13.1. Introduction
• 13.2. Diagnostic Laboratories
• 13.3. Hospitals & Clinics
  • 13.3.1. Ambulatory Surgical Centers
  • 13.3.2. Specialty Centers
• 13.4. Rehabilitation Centers
• 13.5. Research & Academic Institutes

14. Medical Robots Market, by Distribution Channels

• 14.1. Introduction
• 14.2. Offline
  • 14.2.1. Direct Sale
  • 14.2.2. Distributors Network
• 14.3. Online

15. Medical Robots Market, by Region

• 15.1. Europe
• 15.2. Asia-Pacific
• 15.3. North America
• 15.4. Latin America
• 15.5. Middle East
• 15.6. Africa

16. Medical Robots Market, by Group

• 16.1. NATO
• 16.2. G7
• 16.3. European Union
• 16.4. BRICS
• 16.5. ASEAN
• 16.6. GCC

17. Medical Robots Market, by Country

• 17.1. United States
• 17.2. China
• 17.3. Germany
• 17.4. Japan
• 17.5. India
• 17.6. United Kingdom
• 17.7. Brazil
• 17.8. France
• 17.9. Mexico
• 17.10. Canada
• 17.11. Australia
• 17.12. South Korea
• 17.13. Italy
• 17.14. Spain
• 17.15. Russia

18. Competitive Landscape

• 18.1. Market Share Analysis, 2025
• 18.2. FPNV Positioning Matrix, 2025
• 18.3. Market Concentration Analysis, 2025
  • 18.3.1. Concentration Ratio (CR)
  • 18.3.2. Herfindahl Hirschman Index (HHI)
• 18.4. Recent Developments & Impact Analysis, 2025
• 18.5. Product Portfolio Analysis, 2025
• 18.6. Benchmarking Analysis, 2025

19. Company Profiles

• 19.1. ABB Ltd.
• 19.2. Accuray Incorporated
• 19.3. Aethon, Inc. by ST Engineering
• 19.4. Aldebaran SAS
• 19.5. ARxIUM
• 19.6. CMR Surgical Limited
• 19.7. DENSO Corporation
• 19.8. Diligent Robotics, Inc.
• 19.9. Freehand Ltd.
• 19.10. Globus Medical, Inc.
• 19.11. Guangdong Huayan Robotics Co.,Ltd.
• 19.12. Harmonic Drive SE
• 19.13. Intuitive Surgical, Inc.
• 19.14. Johnson & Johnson Services, Inc.
• 19.15. Kawasaki Heavy Industries, Ltd.
• 19.16. Kinova Inc.
• 19.17. Medtronic PLC
• 19.18. Meril Group
• 19.19. Midea Group
• 19.20. Momentis Innovative Surgery Ltd.
• 19.21. Noah Medical
• 19.22. PROCEPT BioRobotics
• 19.23. Siemens Healthineers
• 19.24. Smith & Nephew PLC
• 19.25. Stryker Corporation
• 19.26. Staubli International AG
• 19.27. Think Surgical Inc.
• 19.28. Triton Medical Robotics
• 19.29. Vicarious Surgical Inc.
• 19.30. XACT Robotics
• 19.31. ZIMMER BIOMET HOLDINGS, INC.